Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome

Aim. To assess comorbidities in elderly patients with acute coronary syndrome (ACS) and to analyze patient subgroups with different treatment strategies in the Regional Vascular Center (RVC).

Material and methods. The prospective study included 205 patients with confirmed ACS 75 years and older, the mean age was 81±4.9 years, and 68% were women. ST segment elevation myocardial infarction (STEMI) was diagnosed in 46 (22.4 %) patients, non-ST segment elevation myocardial infarction (NSTEMI) was diagnosed in 159 (77,6 %) patients. The Charlson Comorbidity Index (CCI) was calculated in every patient. Early outcomes were defined as those assessed during hospital stay. Late outcomes were assessed at 6 months after the discharge using phone calls and/or clinic visits. All patients provided written informed consent.

Results. Percutaneous coronary intervention (PCI) was performed in 42% of patients. In patients with STEMI and NSTEMI PCI was performed in 73% and 32%, respectively. Mean CCI score was 7.9 points: 7.6 points in men and 8.04 in women. Patients with STEMI had higher CCI score than NSTEMI patients (p<0.01): 8.1 points and 7.1 points, respectively. Patients who underwent PCI had lower CCI score (7.2 points) than patients in non-PCI group (8.2 points; p<0.05). Patients with STEMI in PCI and non-PCI groups had significant difference in CCI score (p<0.05): 7.4 and 8.4 points, respectively. Mean CCI score in patients who died in hospital was 8.5 while discharged patients had 7.6 points (p<0.01). In 6 months 13 patients (6.3%) died, their mean age was 84.9 years, mean CCI was 9 points, PCI was performed in 3 (23%) patients.

Conclusions. Elderly patients with ACS had high comorbidity level assessed by CCI score. Higher CCI score was associated with PCI non-performance in elderly patients. Elderly patients with STEMI had higher CCI score than patients with NSTEMI which was significantly associated with PCI non-performance. Patients who died in hospital or in 6 months after the ACS onset had higher CCI score than other elderly patients with ACS.

1. Beard JR, Officer A, de Carvalho IA, et al. The world report on ageing and health: a policy framework for healthy ageing. Lancet. 2016;387(10033):2145-54. DOI:10.1016/S0140-6736(15)00516-4.

2. Petrosyan Y, Kuluski K, Barnsley J, Liu B, Wodchis W. Evaluating quality of overall care among older adults with diabetes with comorbidities in Ontario, Canada: a retrospective cohort study. BMJ Open. 2020;10(2):e033291. DOI:10.1136/bmjopen-2019-033291.

3. Bourgeois FT, Orenstein L, Ballakur S, et al. Exclusion of elderly people from randomized clinical trials of drugs for ischemic heart disease. J Am Geriatr Soc. 2017;65(11):2354-61. DOI:10.1111/jgs.14833.

4. Huntley AL. Measures of multimorbidity and morbidity burden for use in primary care and community settings: A Systematic review and guide. Ann Fam Med. 2012;10:134-41. DOI:10.1370/afm.1363.

5. Charlson ME, Charlson RE, Peterson JC, et al. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol 2008;61(12):1234-40. DOI:10.1016/j.jclinepi.2008.

6. Sanchis J, Soler M, Nunez J, et al. Comorbidity assessment for mortality risk stratification in elderly patients with acute coronary syndrome. Eur J Intern Med. 2019;62:48-53. DOI:10.1016/j.ejim.2019.01.018.

7. Skvortsova NV, Kovynev IB, Khalzov KV, et al. Comorbidity and Personalized Treatment of Multiple Myeloma in Real Clinical Practice. Clinical Oncohematology. 2020;13(3):322-34 (In Russ.) DOI:10.21320/2500-2139-2020-13-3-322-334.

8. Acute coronary syndrome without ST segment elevation electrocardiogram. Russian clinical guidelines (2020). Available from: https://scardio.ru/content/Guidelines/2020/Clinic_rekom_OKS_bST.pdf (In Russ.)

9. Ibanez B, James S, Agewall S, et al 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119-177. DOI:10.1093/eurheartj/ehx393.

10. Staroverov II, Shakhnovich RM, Gilyarov MYu, et al. Eurasian clinical guidelines on diagnosis and treatment of acute coronary syndrome with ST segment elevation (STEMI). Eurasian Heart Journal. 2020;1:4-77 (In Russ.) DOI:10.24411/2076-4766-2020-10001.

11. Tegn N, Abdelnoor M, Aaberge L, et al. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial. Lancet. 2016;387(10023):1057-65. DOI:10.1016/S0140-6736(15)01166-6.

12. Collet JP, Thiele H., Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289-1367. DOI:10.1093/eurheartj/ehaa575.

13. Kim JY, Jeong MH, Choi YW, et al. Korea Acute Myocardial Infarction Registry Investigators. Temporal trends and in-hospital outcomes of primary percutaneous coronary intervention in nonagenarians with ST-segment elevation myocardial infarction. Korean J Intern Med. 2015;30:821-8. DOI:10.3904/kjim.2015.30.6.821.

14. Schoenenberger AW, Radovanovic D, Windecker S, et al. AMIS Plus Investigators. Temporal trends in the treatment and outcomes of elderly patients with acute coronary syndrome. Eur Heart J. 2016;37:1304-11. DOI:10.1093/eurheartj/ehv698.

15. Numasawa Y, Inohara T, Ishii H et al. Comparison of Outcomes After Percutaneous Coronary Intervention in Elderly Patients, Including 10 628 Nonagenarians: Insights From a Japanese Nationwide Registry (J-PCI Registry). J Am Heart Assoc. 2019;8:e011017. DOI:10.1161/JAHA.118.011017.

16. Barbarash OL, Kashtalap VV, Kochergina AM, et al. Management of patients with ST-segment elevation acute coronary syndrome in interventional cardiology units: RECORD-3 registry data. Fun- damrntal and Clinical Medicine. 2016;1(3):6-13 (In Russ.)

17. Erlikh A, Gratsiansky N. Registry of Acute Coronary Syndromes «RECORD-3». Characteristics of Patients and Treatment During Initial Hospitalization. Kardiologiia. 2016;56(4):16-24 (In Russ.) DOI:10.18565/cardio.2016.4.16-24.

18. Chuang AM, Hancock DG, Halabi A, et al. Invasive management of acute coronary syndrome: interaction with competing risks. Int J Cardiol. 2018;269:13-8. DOI:10.1016/j.ijcard.2018.07.078.

19. Barbarash OL, Kashtalap VV, Bykova IS, et al. Gender specifics of clinical course and in-patient stage of management in ST elevation acute coronary syndrome patients (by the Russian registry of acute coronary syndrome “RECORD-3”). Russian Journal of Cardiology. 2017;6:122-31 (In Russ.) DOI:10.15829/1560-4071-2017-6-122-131.

20. Stahli BE, Gebhard C, Yonekawa K, et al. Gender-Related Differences in Patients Presenting with Suspected Acute Coronary Syndromes: Clinical Presentation, Biomarkers and Diagnosis. Cardiology. 2015;132:189-98. DOI:10.1159/000435908.

21. Olivari Z, Steffenino G, Savonitto S, et al. The management of acute myocardial infarction in the car-diological intensive care units in Italy: the 'BLITZ 4 Qualita’ campaign for performance measurement and quality improvement. Eur Heart J Acute Cardiovasc Care. 2012;1(2):143-52. DOI:10.1177/2048872612450520.

22. Nunez J, Nunez E, Facila L, et al. Prognostic value of Charlson Comorbidity Index at 30 days and 1 year after acute myocardial infarction. Rev Esp Cardiol. 2004;57(9):842-9. DOI:10.1016/s1885-5857(06)60649-x.

23. Sanchis J, Nunez E, Barrabes JA, et al. Randomized comparison between the invasive and conservative strategies in comorbid elderly patients with non-ST elevation myocardial infarction. Eur J Intern Med. 2016;35:89-94. DOI:10.1016/j.ejim.2016.07.003.